Successful treatment of aggressive metastatic sebaceous carcinoma with pembrolizumab.

Autor: Jikihara N; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Yokoi K; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Matsumura Y; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Ishitsuka Y; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Kiyohara E; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Watanabe R; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Nojima S; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Fujiwara M; Department of Radiation Oncology, Suita Tokusyukai Hospital, Suita, Osaka, Japan., Fujimoto M; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Tanemura A; Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Jazyk: angličtina
Zdroj: European journal of dermatology : EJD [Eur J Dermatol] 2024 Jun 01; Vol. 34 (3), pp. 308-310.
DOI: 10.1684/ejd.2024.4697
Databáze: MEDLINE